Clinical Research HamburggmbH
Hamburg 22143
0 studies enrolling now · 8 studies all time
What they study most
COVID-19 Prevention, Gastroparesis, Knee Osteoarthritis, Moderate to Severe Plaque Psoriasis, Plaque Type Psoriasis, Psoriasis, Respiratory Syncytial Virus Infection Prevention, Seasonal Influenza
Studies at this site
- A Study of an Ad26.RSV. preF-based Vaccine in Adults Aged 18 to 59 Years, Including Adults at High Risk for Severe RSV Infection — Completed
- A Study to Evaluate Dose Levels of Ad26.COV2.S Administered as a Two-dose Schedule in Healthy Adults — Completed
- A Study of mRNA-1010 Seasonal Influenza Vaccine in Adults 50 Years Old and Older — Completed
- MSB11022 in Moderate to Severe Chronic Plaque Psoriasis — Completed
- A Long-term Study to Evaluate Safety and Maintenance of Treatment Effect of LY3074828 in Participants With Moderate-to-Severe Plaque Psoriasis (OASIS-3) — Stopped early
- Diabetic Gastroparesis Study 05 — Stopped early
- A Study to Evaluate the Efficacy and Safety of Mirikizumab (LY3074828) in Participants With Moderate-to-Severe Plaque Psoriasis — Completed
- Fasitibant Intra-articular Injection in Patients With Symptomatic Osteoarthritis of the Knee — Completed